-
Diagnostics World | Theranos comparisons are generally not favorable, but Babson Diagnostics has now rolled out blood testing that achieves what Theranos claimed to: needle-free, small-volume blood testing, from the convenience of retail pharmacies.
Aug 21, 2024
-
Diagnostics World | New technology, powered by artificial intelligence (AI), aims to bring breast and ovarian cancer patients the expected value of genomic sequencing—a more precise diagnosis and personalized treatment strategy—potentially without ever having their DNA analyzed.
Aug 20, 2024
-
Diagnostics World | Last week, Paige, in collaboration with Microsoft, unveiled the second generation of Virchow, its million-slide foundation model for cancer. Virchow2 and Virchow2G offer a deeper understanding of cells and tissue, aiming to redefine cancer diagnosis and treatment.
Aug 16, 2024
-
Diagnostics World | In recent months, Diagnostics World has taken a look at new developments taking place in the field of sarcoidosis research, including progress made toward a simple blood test and new treatment options as well as efforts to gain a better understanding of cardiac sarcoidosis in particular. Here, we explore the role of philanthropic funding, highlight research projects and collaborative initiatives, and sum up efforts to improve clinical trial diversity.
Aug 15, 2024
-
Diagnostics World | Researchers at The Australian National University (ANU) have developed a deep learning algorithm, known as DEPLOY, to classify central nervous system tumors into 10 major categories from histopathology images. The goal is to optimize treatment with a faster, more accessible diagnostic approach than the state-of-the-art practice of DNA methylation-based profiling, which can take weeks.
Aug 13, 2024
-
Diagnostics World | Obstructive sleep apnea (OSA) is a sleep disorder associated with major cardiovascular complications. Despite being a common sleep disorder, there has not been an effective drug treatment for patients. Fortunately, a team from the University of California San Diego School of Medicine recently published a drug repurposing study that may offer hope.
Aug 8, 2024
-
Diagnostics World | Companion diagnostics (CDx) have revolutionized the treatment of cancer by helping to improve the safety and tolerability of targeted drugs—a key feature of precision medicine. The U.S. Food and Drug Administration (FDA) has to date approved nearly 180 CDx, many for rare diseases but only four of those outside of oncology.
Aug 7, 2024
-
Diagnostics World | GE HealthCare and Amazon Web Services have announced a strategic collaboration to develop purpose-built foundation models and generative artificial intelligence (AI) applications designed to help clinicians improve medical diagnostics and patient care.
Aug 6, 2024